Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) Income towards Parent Company (2022 - 2025)

Historic Income towards Parent Company for Core Laboratories (CLB) over the last 4 years, with Q3 2025 value amounting to $14.5 million.

  • Core Laboratories' Income towards Parent Company rose 2070.03% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.7 million, marking a year-over-year increase of 10447.99%. This contributed to the annual value of $32.2 million for FY2024, which is 2384.16% up from last year.
  • Latest data reveals that Core Laboratories reported Income towards Parent Company of $14.5 million as of Q3 2025, which was up 2070.03% from $10.7 million recorded in Q2 2025.
  • Over the past 5 years, Core Laboratories' Income towards Parent Company peaked at $23.0 million during Q2 2023, and registered a low of -$8.6 million during Q4 2023.
  • For the 4-year period, Core Laboratories' Income towards Parent Company averaged around $7.4 million, with its median value being $7.6 million (2022).
  • Data for Core Laboratories' Income towards Parent Company shows a peak YoY increase of 22148.36% (in 2023) and a maximum YoY decrease of 24301.34% (in 2023) over the last 5 years.
  • Core Laboratories' Income towards Parent Company (Quarter) stood at $6.0 million in 2022, then tumbled by 243.01% to -$8.6 million in 2023, then skyrocketed by 187.05% to $7.5 million in 2024, then soared by 92.76% to $14.5 million in 2025.
  • Its Income towards Parent Company stands at $14.5 million for Q3 2025, versus $10.7 million for Q2 2025 and $69000.0 for Q1 2025.